Our findings were consistent with two other studies stating that an increased level of IL-1β is associated with NSCLC cell proliferation [109,110] and there is a negative correlation between IL-1β and progression-free survival of patients with NSCLC [109]. Here, IL1B is linked to non-small cell lung carcinoma.